The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-Hsct) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.442
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2015
Authors
Publisher
Elsevier BV